| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.05. | Earnings call: MediWound reports a revenue increase to $5 million in Q1 | 1 | Investing.com | ||
| 29.05. | MediWound GAAP EPS of -$1.05 misses by $0.64, revenue of $4.96M beats by $0.29M | 1 | Seeking Alpha | ||
| 29.05. | MediWound Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.05. | MediWound Ltd.: MediWound Reports First Quarter 2024 Financial Results and Provides Company Update | 121 | GlobeNewswire (Europe) | NexoBrid® interest surges; $5 million in Q1 2024 revenue, with $24 million forecast for the year Manufacturing facility on target for completion by mid-2024 EscharEx® Phase III study to launch 2H... ► Artikel lesen | |
| 28.05. | MediWound Q1 2024 Earnings Preview | 1 | Seeking Alpha | ||
| 22.05. | MediWound Ltd.: MediWound to Report First Quarter 2024 Financial Results | 2 | GlobeNewswire (USA) | ||
| 22.03. | Earnings call: MediWound forecasts growth with NexoBrid and EscharEx advances | 1 | Investing.com | ||
| 21.03. | MediWound Ltd. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 21.03. | MediWound reports mixed Q4 results; initiates FY24 outlook | 1 | Seeking Alpha | ||
| 21.03. | MediWound Ltd.: MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update | 139 | GlobeNewswire (Europe) | $19 million revenue in 2023; $24 million projected revenue in 2024NexoBrid® commercially launched in U.S., Japan, IndiaPotential blockbuster EscharEx® to begin Phase III in the second half of 2024$42... ► Artikel lesen | |
| 21.03. | MediWound Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 20.03. | Preview: MediWound's Earnings | 1 | Benzinga.com | ||
| 20.03. | MediWound Q4 2023 Earnings Preview | 1 | Seeking Alpha | ||
| 12.02. | MediWound stock climbs 9% on Phase 2 data for wound care treatment | 2 | Seeking Alpha | ||
| 12.02. | MediWound Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 05.02. | MediWound Ltd.: MediWound to Participate in Two Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
| 09.01. | FDA accepts MediWound application for NexoBrid pediatric approval | 1 | Seeking Alpha | ||
| 09.01. | MediWound: FDA To Review NexoBrid SBLA For Removal Of Eschar In Pediatric Patients | 2 | RTTNews | ||
| 08.01. | MediWound Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 29.12.23 | MediWound Receives $6.7 Million U.S. DoD Funding For Advancing NexoBrid Development | 3 | pulse2.com |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.520 |
| NVIDIA | 1.798 |
| TUI | 1.543 |
| BAYER | 1.138 |
| NEL | 1.127 |
| GAMESTOP | 1.076 |
| RHEINMETALL | 1.005 |
| BYD | 865 |
| DEUTSCHE LUFTHANSA | 767 |
| VOLKSWAGEN | 560 |
| TESLA | 469 |
| SNOWFLAKE | 468 |
| BASF | 444 |
| THYSSENKRUPP | 435 |
| AIXTRON SE | 395 |
| COMMERZBANK | 386 |
| PORSCHE SE | 383 |
| APPLE | 366 |
| DEFI TECHNOLOGIES | 352 |
| MERCEDES-BENZ | 352 |
| ALLIANZ | 346 |
| CAVENDISH HYDROGEN | 344 |
| DEUTSCHE BANK | 344 |
| RWE | 331 |
| THYSSENKRUPP NUCERA | 305 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
